NBC News
@NBCNews·11.9M subscribers·98K videos
FDA greenlights new Alzheimer's drug amid safety concerns
Posted
January 7, 2023
Views
13,803
Likes
61
Comments
29
Engagement
0.65%
January 7, 2023
13,803
61
29
0.65%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:10Now PlayingThe FDA is greenlighting the drug Leqembi after it appeared to slow cognitive decline in some early stage Alzheimer’s patients in spite of some potential risks. NBC News’ Kristen Dahlgren has more details about findings from a clinical trial.
» Subscribe to NBC News
» Watch more NBC video
NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.
Connect with NBC News Online!
NBC News App
Breaking News Alerts
Visit NBCNews.Com
Find NBC News on Facebook
Follow NBC News on Twitter
#NBCNews #Alzheimer #FDA
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
